Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children

Elisa Mazzoni, Francesca Frontini, John Charles Rotondo, Nunzia Zanotta, Arianna Fioravanti, Francesca Minelli, Elena Torreggiani, Giuseppina Campisciano, Annalisa Marcuzzi, Giovanni Guerra, Alberto Tommasini, Antoine Touzé, Fernanda Martini, Mauro Tognon, Manola Comar

Research output: Contribution to journalArticle

Abstract

Recent data indicate that the Simian virus 40 (SV40) infection appears to be transmitted in humans independently from early SV40-contaminated antipolio vaccines. Serum antibodies against SV40 large T antigen (Tag) were analyzed in children/adolescents and young adults. To investigate antibodies reacting to SV40 Tag antigens, serum samples (n = 812) from children and young adults were analyzed by indirect ELISAs using specific SV40 Tag mimotopes. Mimotopes were synthetic peptides corresponding to SV40 Tag epitopes. In sera (n = 412) from healthy children up to 17 years old, IgG antibodies against SV40 Tag mimotopes reached an overall prevalence of 15%. IgM antibodies against SV40 Tag were detected in sera of children 6–8 months old confirming and extending the knowledge that SV40 seroconversion occurs early in life. In children/adolescents affected by different diseases (n = 180) SV40 Tag had a prevalence of 18%, being the difference no significant compared to healthy subjects (n = 220; 16%) of the same age. Our immunological data indicate that SV40 circulates in children and young adults, both in healthy conditions and affected by distinct diseases. The IgM detection in sera from healthy children suggests that the SV40 infection/seroconversion occurs early in life (>6 months). Our immunological data support the hypothesis that SV40, or a closely related still unknown polyomavirus, infects humans. The SV40 seroprevalence is lower than common polyomaviruses, such as BKPyV and JCPyV, and other new human polyomaviruses. In addition, our immunological surveillance indicates a lack of association between different diseases, considered herein, and SV40.

Original languageEnglish
Pages (from-to)3170-3179
Number of pages10
JournalJournal of Cellular Physiology
Volume234
Issue number4
DOIs
Publication statusPublished - Apr 1 2019

Fingerprint

Simian virus 40
Oncogene Proteins
Viral Tumor Antigens
Viruses
Antibodies
Serum
Polyomavirus
Young Adult
Virus Diseases
Immunoglobulin M
Immunologic Surveillance
Seroepidemiologic Studies

Keywords

  • antibody
  • child
  • disease
  • immunity
  • prevalence
  • SV40
  • Tag

ASJC Scopus subject areas

  • Physiology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children. / Mazzoni, Elisa; Frontini, Francesca; Rotondo, John Charles; Zanotta, Nunzia; Fioravanti, Arianna; Minelli, Francesca; Torreggiani, Elena; Campisciano, Giuseppina; Marcuzzi, Annalisa; Guerra, Giovanni; Tommasini, Alberto; Touzé, Antoine; Martini, Fernanda; Tognon, Mauro; Comar, Manola.

In: Journal of Cellular Physiology, Vol. 234, No. 4, 01.04.2019, p. 3170-3179.

Research output: Contribution to journalArticle

Mazzoni, E, Frontini, F, Rotondo, JC, Zanotta, N, Fioravanti, A, Minelli, F, Torreggiani, E, Campisciano, G, Marcuzzi, A, Guerra, G, Tommasini, A, Touzé, A, Martini, F, Tognon, M & Comar, M 2019, 'Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children' Journal of Cellular Physiology, vol. 234, no. 4, pp. 3170-3179. https://doi.org/10.1002/jcp.27490
Mazzoni, Elisa ; Frontini, Francesca ; Rotondo, John Charles ; Zanotta, Nunzia ; Fioravanti, Arianna ; Minelli, Francesca ; Torreggiani, Elena ; Campisciano, Giuseppina ; Marcuzzi, Annalisa ; Guerra, Giovanni ; Tommasini, Alberto ; Touzé, Antoine ; Martini, Fernanda ; Tognon, Mauro ; Comar, Manola. / Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children. In: Journal of Cellular Physiology. 2019 ; Vol. 234, No. 4. pp. 3170-3179.
@article{d18dc3226eaf47c5becfa676fcca0f6f,
title = "Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children",
abstract = "Recent data indicate that the Simian virus 40 (SV40) infection appears to be transmitted in humans independently from early SV40-contaminated antipolio vaccines. Serum antibodies against SV40 large T antigen (Tag) were analyzed in children/adolescents and young adults. To investigate antibodies reacting to SV40 Tag antigens, serum samples (n = 812) from children and young adults were analyzed by indirect ELISAs using specific SV40 Tag mimotopes. Mimotopes were synthetic peptides corresponding to SV40 Tag epitopes. In sera (n = 412) from healthy children up to 17 years old, IgG antibodies against SV40 Tag mimotopes reached an overall prevalence of 15{\%}. IgM antibodies against SV40 Tag were detected in sera of children 6–8 months old confirming and extending the knowledge that SV40 seroconversion occurs early in life. In children/adolescents affected by different diseases (n = 180) SV40 Tag had a prevalence of 18{\%}, being the difference no significant compared to healthy subjects (n = 220; 16{\%}) of the same age. Our immunological data indicate that SV40 circulates in children and young adults, both in healthy conditions and affected by distinct diseases. The IgM detection in sera from healthy children suggests that the SV40 infection/seroconversion occurs early in life (>6 months). Our immunological data support the hypothesis that SV40, or a closely related still unknown polyomavirus, infects humans. The SV40 seroprevalence is lower than common polyomaviruses, such as BKPyV and JCPyV, and other new human polyomaviruses. In addition, our immunological surveillance indicates a lack of association between different diseases, considered herein, and SV40.",
keywords = "antibody, child, disease, immunity, prevalence, SV40, Tag",
author = "Elisa Mazzoni and Francesca Frontini and Rotondo, {John Charles} and Nunzia Zanotta and Arianna Fioravanti and Francesca Minelli and Elena Torreggiani and Giuseppina Campisciano and Annalisa Marcuzzi and Giovanni Guerra and Alberto Tommasini and Antoine Touz{\'e} and Fernanda Martini and Mauro Tognon and Manola Comar",
year = "2019",
month = "4",
day = "1",
doi = "10.1002/jcp.27490",
language = "English",
volume = "234",
pages = "3170--3179",
journal = "Journal of Cellular Physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children

AU - Mazzoni, Elisa

AU - Frontini, Francesca

AU - Rotondo, John Charles

AU - Zanotta, Nunzia

AU - Fioravanti, Arianna

AU - Minelli, Francesca

AU - Torreggiani, Elena

AU - Campisciano, Giuseppina

AU - Marcuzzi, Annalisa

AU - Guerra, Giovanni

AU - Tommasini, Alberto

AU - Touzé, Antoine

AU - Martini, Fernanda

AU - Tognon, Mauro

AU - Comar, Manola

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Recent data indicate that the Simian virus 40 (SV40) infection appears to be transmitted in humans independently from early SV40-contaminated antipolio vaccines. Serum antibodies against SV40 large T antigen (Tag) were analyzed in children/adolescents and young adults. To investigate antibodies reacting to SV40 Tag antigens, serum samples (n = 812) from children and young adults were analyzed by indirect ELISAs using specific SV40 Tag mimotopes. Mimotopes were synthetic peptides corresponding to SV40 Tag epitopes. In sera (n = 412) from healthy children up to 17 years old, IgG antibodies against SV40 Tag mimotopes reached an overall prevalence of 15%. IgM antibodies against SV40 Tag were detected in sera of children 6–8 months old confirming and extending the knowledge that SV40 seroconversion occurs early in life. In children/adolescents affected by different diseases (n = 180) SV40 Tag had a prevalence of 18%, being the difference no significant compared to healthy subjects (n = 220; 16%) of the same age. Our immunological data indicate that SV40 circulates in children and young adults, both in healthy conditions and affected by distinct diseases. The IgM detection in sera from healthy children suggests that the SV40 infection/seroconversion occurs early in life (>6 months). Our immunological data support the hypothesis that SV40, or a closely related still unknown polyomavirus, infects humans. The SV40 seroprevalence is lower than common polyomaviruses, such as BKPyV and JCPyV, and other new human polyomaviruses. In addition, our immunological surveillance indicates a lack of association between different diseases, considered herein, and SV40.

AB - Recent data indicate that the Simian virus 40 (SV40) infection appears to be transmitted in humans independently from early SV40-contaminated antipolio vaccines. Serum antibodies against SV40 large T antigen (Tag) were analyzed in children/adolescents and young adults. To investigate antibodies reacting to SV40 Tag antigens, serum samples (n = 812) from children and young adults were analyzed by indirect ELISAs using specific SV40 Tag mimotopes. Mimotopes were synthetic peptides corresponding to SV40 Tag epitopes. In sera (n = 412) from healthy children up to 17 years old, IgG antibodies against SV40 Tag mimotopes reached an overall prevalence of 15%. IgM antibodies against SV40 Tag were detected in sera of children 6–8 months old confirming and extending the knowledge that SV40 seroconversion occurs early in life. In children/adolescents affected by different diseases (n = 180) SV40 Tag had a prevalence of 18%, being the difference no significant compared to healthy subjects (n = 220; 16%) of the same age. Our immunological data indicate that SV40 circulates in children and young adults, both in healthy conditions and affected by distinct diseases. The IgM detection in sera from healthy children suggests that the SV40 infection/seroconversion occurs early in life (>6 months). Our immunological data support the hypothesis that SV40, or a closely related still unknown polyomavirus, infects humans. The SV40 seroprevalence is lower than common polyomaviruses, such as BKPyV and JCPyV, and other new human polyomaviruses. In addition, our immunological surveillance indicates a lack of association between different diseases, considered herein, and SV40.

KW - antibody

KW - child

KW - disease

KW - immunity

KW - prevalence

KW - SV40

KW - Tag

UR - http://www.scopus.com/inward/record.url?scp=85055505518&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055505518&partnerID=8YFLogxK

U2 - 10.1002/jcp.27490

DO - 10.1002/jcp.27490

M3 - Article

VL - 234

SP - 3170

EP - 3179

JO - Journal of Cellular Physiology

JF - Journal of Cellular Physiology

SN - 0021-9541

IS - 4

ER -